How do I find a licensed psilocybin facilitator in Oregon or Colorado?

Oregon: The Oregon Health Authority maintains a public registry of all licensed psilocybin service centers and facilitators at psilocybinservices.oregon.gov. You can search by location and book directly. Colorado: The Department of Regulatory Agencies (DORA) maintains a registry of licensed healing centers at dora.colorado.gov/natural-medicine. You can also use directories like Psychedelic.support, Synthesis Institute's directory, or Integration Alliance to find vetted facilitators. Look for state-licensed facilitators (required in OR/CO), therapist credentials if you need clinical support, and clear pricing/informed consent processes.

How do I join a psilocybin or MDMA clinical trial?

Clinical trials are the best option for people who want free or subsidized access and contribution to research. Steps: (1) Go to ClinicalTrials.gov and search for 'psilocybin' or 'MDMA' — filter by 'Recruiting' status and your location. (2) Review eligibility criteria carefully — most trials exclude people with personal or family history of psychosis, certain medications (especially SSRIs/SNRIs which may need to be tapered), and some medical conditions. (3) Contact the study coordinator using the contact info listed. (4) Complete a screening call. Major active programs: COMPASS Pathways (NCT05548439 — TRD), Usona Institute (depression), Johns Hopkins (multiple conditions), NYU Langone (AUD, depression), MAPS (MDMA-PTSD). Most are located in major US cities and academic centers.

What are the red flags to avoid when seeking psychedelic therapy?

Red flags: (1) Anyone offering psilocybin therapy outside Oregon, Colorado, or a licensed clinical trial in the US — this is illegal regardless of claimed therapeutic context. (2) Facilitators without state licensure in OR/CO or institutional affiliation in trials. (3) Anyone who promises specific outcomes or cure claims. (4) Pressure to pay large sums upfront with no refund policy. (5) Lack of preparation and integration sessions — reputable programs always include these. (6) Combining psilocybin with other substances without medical supervision. (7) Anyone willing to proceed without a proper intake screening for contraindications. Green flags: state license number, transparent pricing, integration support included, clear informed consent process, screened for contraindications.

How to Find Psychedelic Therapy Near You in 2026

Q: When will psychedelic therapy be available in my state?

OOTWOracle's 8-agent AI system tracks all state-level psychedelic legislation daily. As of June 2026, Oregon and Colorado have operational regulated access. California (SB 58) decriminalized personal use in 2023 but regulated service centers are pending. States with active 2026 legislation include Washington, Nevada, Minnesota, New Mexico, Vermont, and Massachusetts. OOTWOracle gives 41% odds that 5+ states will have operational psilocybin service centers by 2028. The fastest path to wider access is FDA approval of psilocybin — if approved, medical prescriptions would become available nationwide. OOTWOracle gives 52% odds on FDA approval for TRD by early 2028.

US states with licensed psilocybin therapy (OR + CO)

200+

Active psychedelic clinical trials recruiting participants

Cost to join most psilocybin clinical trials

Countries with fully legal psilocybin therapy access

52%

Oracle: FDA approval for TRD by early 2028

Important legal note: Psychedelic therapy involving psilocybin, MDMA, or other Schedule I substances is only legal in the US within the two states listed below or in an FDA-approved clinical trial. "Underground" therapy — however well-intentioned — carries serious legal risk for both client and facilitator. This guide covers only legal, verified access paths.

Your 6 Legal Access Paths in 2026

Choose the path that fits your location, budget, condition, and timeline. Most people start by checking clinical trials first (free, research-backed) then Oregon/Colorado service centers (accessible, no prescription needed).

🟢 Live Now — US

Oregon Psilocybin Service Centers

Oregon's Measure 109 created the first regulated psilocybin therapy system in the US. No prescription, no diagnosis required — adults 21+ can book directly with licensed facilitators.

$1,500 – $3,500 · Insurance: Not yet covered

🟢 Live Now — US

Colorado Natural Medicine Healing Centers

Colorado Prop 122 licensed healing centers opened in 2024. Similar model to Oregon — no prescription needed, supervised psilocybin sessions with licensed facilitators.

$1,500 – $3,000 · Insurance: Not yet covered

🔵 Recruiting — Nationwide

FDA Clinical Trials

200+ active trials across the US at major research centers. Free sessions, full medical supervision, cutting-edge protocols. Best for people with specific diagnoses (TRD, PTSD, AUD, anxiety).

$0 (free) · Some trials pay participants

🟡 FDA-Approved — Nationwide

Ketamine / Spravato Clinics

Ketamine is Schedule III and fully FDA-approved. IV ketamine clinics operate in every major US city. Spravato (esketamine) is FDA-approved for TRD and partially covered by insurance.

$400 – $800/session IV · Spravato: copay w/ insurance

🟣 International — Legal

Jamaica & Netherlands Retreats

Jamaica has no laws scheduling psilocybin mushrooms — retreats operate legally. Netherlands allows psilocybin truffle retreats. Fully above-board, professional therapeutic settings.

$2,500 – $6,000 · Travel additional

🟣 International — Legal

Australia & Peru

Australia's TGA approved psilocybin therapy for TRD in 2023 — available through authorized psychiatrists. Peru offers legal ayahuasca retreats in a traditional ceremonial framework.

Australia: $3,000–$8,000 · Peru: $1,500–$5,000

Oregon: How to Find a Licensed Psilocybin Facilitator

Oregon was the first US state to license regulated psilocybin therapy. The Oregon Health Authority (OHA) licenses both Service Centers (physical locations) and individual Facilitators. As of 2026, 50+ service centers are operational statewide, concentrated in Portland, Eugene, Bend, and Ashland.

Step-by-Step: Finding an Oregon Facilitator

Oregon Health Authority Registry: Visit oregon.gov/oha psilocybin services to search the official registry of all licensed service centers and facilitators. This is the only authoritative source — anyone claiming licensure not on this list should be avoided.
Directories: Psychedelic.support and the Integration Alliance directory list vetted Oregon providers with client reviews, therapist credentials, and specialties.
Check the license number: Any legitimate Oregon service center will display their OHA license number. Cross-check on the OHA registry before booking.
Preparation consultation: By Oregon law, all sessions must be preceded by a preparation session. This is where you discuss your intention, medical history, and what to expect.
Integration support: Ask whether the provider includes post-session integration support. The quality of this support significantly influences outcomes.

Oregon sessions typically include: preparation meeting (1-2hrs), psilocybin session (4-8hrs, facilitator present the entire time), and follow-up integration. Doses range from low (5-10mg psilocybin equivalent) to high (25-35mg) depending on your goals and the facilitator's assessment.

Colorado: Natural Medicine Healing Centers

Colorado's Proposition 122 (2022) created a regulated Natural Medicine Health Act that covers psilocybin, psilocin, DMT, mescaline, and ibogaine — the most comprehensive state framework in the US. Healing centers licensed under the Department of Regulatory Agencies (DORA) began operating in 2024.

Colorado vs. Oregon: Key Differences

Feature	Oregon	Colorado
Substances covered	Psilocybin only	Psilocybin, DMT, mescaline, ibogaine (ibogaine: pending cardiac safety rules)
Age minimum	21+	21+
Prescription required	No	No
Personal possession	Decriminalized with therapy context	Decriminalized up to personal use amounts
Facilitator training	160-hr OHA curriculum	Ongoing DORA curriculum
Registry	OHA registry (public)	DORA registry (public)
Estimated service centers (2026)	50+	30+

Clinical Trials: Free or Low-Cost Access to Research-Grade Therapy

For many people — especially those with a specific diagnosis like depression, PTSD, or alcohol use disorder — clinical trials offer the highest-quality access to psychedelic therapy. Sessions are conducted by expert teams, fully supervised medically, and often free or compensated.

Who qualifies for trials: Requirements vary by study. Most trials require a confirmed diagnosis (TRD, PTSD, AUD, etc.) and exclude people with personal or family history of psychosis, certain cardiac conditions, and some medications (particularly SSRIs which typically require tapering). Don't self-disqualify before talking to the study coordinator — criteria are more flexible than they appear.

How to Find and Join a Trial

ClinicalTrials.gov: Go to clinicaltrials.gov → search "psilocybin" or "MDMA" → filter by Status: "Recruiting" → filter by Country: "United States" → filter by condition if you have one.
Review eligibility criteria: Each trial listing has detailed inclusion/exclusion criteria. Read these before contacting the study team.
Contact the study coordinator: The listing includes contact info. Email or call — coordinators are helpful and accustomed to screening questions. This is not a commitment.
Phone screening: You'll have a 20-30 minute call to determine eligibility. Be honest about your medical history — this protects you.
In-person screening visit: If phone-eligible, you'll visit the study site for a baseline evaluation. You can still withdraw at any point before the session.

Major Active Trial Programs (June 2026)

Institution	Compound	Conditions	Location(s)
COMPASS Pathways	COMP360 (psilocybin 25mg)	TRD (Phase 3)	Multiple US + EU sites
Usona Institute	Psilocybin	MDD	Madison WI, multiple sites
Johns Hopkins	Psilocybin	Depression, AUD, smoking, anxiety	Baltimore MD
NYU Langone	Psilocybin	AUD, MDD, end-of-life	New York NY
UCSF	Psilocybin	GAD, OUD, MDD	San Francisco CA
MAPS PBC	MDMA	PTSD (Phase 3 ongoing)	Multiple US sites
Stanford	MDMA, ibogaine	PTSD, veterans TBI	Palo Alto CA
Imperial College London	Psilocybin, DMT	Depression, consciousness	London UK

Ketamine: The Legal Bridge Available Everywhere Now

While waiting for psilocybin or MDMA access to expand, ketamine is the most accessible psychedelic-adjacent therapy available in 2026 — with a clear FDA approval, insurance coverage pathways, and thousands of clinics nationwide.

Three Ketamine Access Routes

Route	What It Is	Cost	Insurance
IV Ketamine Infusions	Off-label use for TRD, PTSD, chronic pain. Ketamine Advocacy Network has clinic directory	$400–$800/session	Rarely covered (some exceptions)
Spravato (esketamine)	FDA-approved nasal spray for TRD. Administered in certified provider offices. REMS program	Copay $10–$100 with insurance	Yes — covered with TRD diagnosis
Oral/IM Ketamine	Telemedicine-prescribed compounded ketamine (post-DEA crackdown in 2024, availability reduced)	$200–$400/month	Rarely covered

Ketamine works through NMDA receptor blockade and has proven efficacy for treatment-resistant depression and PTSD. Effects are faster than SSRIs (often within hours) but shorter-lasting than psilocybin (maintenance sessions needed). It's a meaningful option — not a second-best consolation prize.

International: Legal Psychedelic Therapy Abroad

For US residents willing to travel, several countries offer fully legal therapeutic psychedelic experiences. These are not "gray zone" — they are explicitly legal and professionally run.

✅ Legal

🇯🇲 Jamaica

Psilocybin mushrooms have never been scheduled in Jamaica. Multiple retreat centers operate openly and professionally. No medical prerequisite — any adult can attend.

$2,500 – $6,000 including accommodation · 3–7 days

✅ Legal (Truffles)

🇳🇱 Netherlands

Psilocybin mushrooms are banned but psilocybin truffles (sclerotia) are completely legal. Multiple Amsterdam-based retreat centers offer therapeutic sessions with therapist support.

$2,000 – $5,000 · Weekend format available

✅ World First

🇦🇺 Australia

Australia's TGA approved psilocybin for TRD and MDMA for PTSD in February 2023 — the first country to do so at a national level. Access through authorized prescribing psychiatrists only.

$3,000 – $8,000 depending on psychiatrist and sessions

✅ Traditional Legal

🇵🇪 Peru

Ayahuasca ceremonies are legal and culturally protected in Peru. Many retreat centers operate in Iquitos and the Sacred Valley, some with integration therapy frameworks.

$1,500 – $5,000 · 7–14 day programs common

✅ Traditional Legal

🇧🇷 Brazil

Ayahuasca was legalized in 1987 for religious use. The União do Vegetal (UDV) and Santo Daime churches operate globally under Brazilian law. Secular retreat centers also operate.

$1,000 – $4,000 · Ceremonial frameworks vary

✅ Legal

🇨🇷 Costa Rica

No specific laws against psilocybin mushrooms. Multiple retreat centers operate in the jungles near Uvita and the Nicoya Peninsula offering psilocybin and ibogaine programs.

$2,000 – $6,000 · Ibogaine programs also available

Red Flags & Green Flags: Vetting a Provider

The psychedelic therapy space is growing fast. Most providers are ethical and professional — but there are also bad actors. Here's how to tell the difference.

🚩 Red Flags — Avoid

❌Operating outside OR/CO or a licensed trial in the US — this is federal crime regardless of how it's framed

❌No state license number or institutional affiliation they can verify

❌Promises specific outcomes ("this will cure your depression")

❌Large upfront payment required with no refund policy

❌Skips medical intake screening or dismisses contraindications

❌Combines psilocybin with MDMA, cannabis, or other substances without medical justification

❌No preparation or integration sessions included in the program

❌Facilitator has no verifiable training history

✅ Green Flags — Trustworthy

✓State license number verifiable in OR/CO public registry

✓Thorough intake screening including medical history and contraindications

✓Preparation session included before the psilocybin session

✓Integration support included after the session (at minimum a follow-up call)

✓Transparent, itemized pricing with written agreement

✓Facilitator credentials and training history available on request

✓Honest framing of what psilocybin therapy can and cannot do

✓Clear informed consent process including risks discussion

Oracle Predictions: When Will Access Expand to Your State?

OOTWOracle's 8-agent AI system runs daily analysis on state-level psychedelic legislation. Here are the current confidence estimates for access expansion.

52%

FDA approves psilocybin for TRD by Q1 2028 — enabling nationwide medical prescription access

41%

5+ states have operational psilocybin service centers by end of 2028

67%

Insurance coverage begins for psilocybin within 2 years of any FDA approval

38%

MDMA therapy receives FDA approval by 2028, enabling PTSD access nationwide

29%

California, Washington, or Nevada launches statewide psilocybin program by 2027

71%

Oregon and Colorado service centers expand to 100+ locations by 2027 as demand grows

Agent Perspectives on Access Expansion

FDA Regulatory Reviewer

"The Oregon and Colorado programs are generating exactly the kind of real-world safety and efficacy data the FDA needs. We're watching patient outcomes carefully. If psilocybin receives NDA approval, the REMS requirements will be demanding — certified treatment centers, trained prescribers, patient monitoring — but access would be nationwide through medical channels."

Veteran Advocate

"The 35% wait time in VA mental health services is a crisis. Veterans are traveling to Oregon, Jamaica, and Mexico on their own dime because they're not willing to wait for the system to catch up. The Trump EO fast-track mandate for veterans is the most important policy shift — if VA pilots succeed, you could see a completely different access model for this population."

Biotech Investor

"The access question is ultimately a business model question. Service centers in Oregon and Colorado are expensive and not scaling fast enough to meet demand. The capital will follow FDA approval — that's when you'll see real infrastructure buildout. The clinical trial ecosystem is the smart play right now: you get access, contribute to data that accelerates approval, and the therapy is free."

MAPS Researcher

"We deliberately designed the clinical trial consent process to be as inclusive as possible. The exclusion criteria that people worry about — previous mental illness, current medications — are narrower than they appear. SSRIs can be tapered. A family history of schizophrenia doesn't automatically exclude you. I'd encourage anyone curious to call the study coordinator before self-disqualifying. The answer is often 'yes, you qualify.'"

Cost Comparison: All Access Paths Side by Side

Access Path	Cost Range	Insurance	Time to Access	Supervised
Clinical Trial	$0 (free)	N/A	2–8 weeks screening	Yes — expert team
Oregon Service Center	$1,500–$3,500	Not covered	Days to weeks	Yes — licensed facilitator
Colorado Healing Center	$1,500–$3,000	Not covered	Days to weeks	Yes — licensed facilitator
Spravato (esketamine)	Copay w/ insurance	Yes (TRD dx)	Prescription + REMS setup	Yes — in-office
IV Ketamine Clinic	$400–$800/session	Rarely	Immediate availability	Yes — clinical
Jamaica Retreat	$2,500–$6,000	Not covered	Book 1–3 months ahead	Yes — retreat staff
Netherlands Retreat	$2,000–$5,000	Not covered	Book weeks ahead	Yes — retreat staff
Peru Ayahuasca Retreat	$1,500–$5,000	Not covered	Flexible	Yes — curandero + staff
Australia Psilocybin (TRD only)	$3,000–$8,000	Partial	Psychiatrist referral	Yes — authorized psychiatrist

Frequently Asked Questions

In 2026, you can access legal psilocybin therapy in two US states: Oregon (psilocybin service centers licensed since 2023) and Colorado (healing centers operational since 2024 under Prop 122). There is no prescription required in either state — adults 21+ can book sessions directly with licensed facilitators. Additionally, multiple cities have decriminalized personal use (Denver, Oakland, DC, Seattle, and 20+ others) though decriminalization does not provide access to supervised therapy. Clinical trials offer another legal path — over 200 active trials are recruiting participants for free or low-cost sessions at major research centers.

Oregon psilocybin service center costs range from $1,500–$3,500 for a full program (preparation session + psilocybin session + integration). Colorado healing centers are similar. Clinical trials are free (some pay participants). Ketamine infusions cost $400–$800 per session (partially insurance-covered via Spravato). Jamaica retreat programs range from $2,500–$6,000. Peru ayahuasca retreats are $1,500–$5,000. Insurance does not yet cover psilocybin therapy in Oregon or Colorado as of 2026, though OOTWOracle gives 67% odds that insurance coverage expands within 2 years of any FDA approval.

Oregon: The Oregon Health Authority maintains a public registry of all licensed psilocybin service centers and facilitators at oregon.gov/oha psilocybin services. You can search by location and book directly. Colorado: DORA maintains a registry of licensed healing centers. You can also use directories like Psychedelic.support, Synthesis Institute's directory, or Integration Alliance to find vetted facilitators. Look for state-licensed facilitators (required in OR/CO), therapist credentials if you need clinical support, and clear pricing/informed consent processes.

Go to ClinicalTrials.gov and search for 'psilocybin' or 'MDMA' — filter by 'Recruiting' status and your location. Review eligibility criteria carefully (most trials exclude people with personal/family history of psychosis, certain medications especially SSRIs, and some medical conditions). Contact the study coordinator using the contact info listed — this is not a commitment. You'll have a phone screening call then possibly an in-person visit. Major programs: COMPASS Pathways (TRD), Usona (MDD), Johns Hopkins (multiple), NYU Langone (AUD, depression), MAPS (MDMA-PTSD).

Red flags: Anyone offering psilocybin outside Oregon, Colorado, or a clinical trial in the US (illegal regardless of framing). Facilitators without verifiable state licensure. Promises of specific cures. Large upfront payments with no refund policy. No preparation or integration sessions included. Skipping medical intake screening. Combining substances without medical justification. Green flags: Verifiable state license, thorough intake screening, preparation and integration included, transparent pricing, informed consent process, honest framing of risks and outcomes.

As of June 2026, Oregon and Colorado have operational licensed access. California decriminalized personal use (SB 58, 2023) but service centers are pending. States with active 2026 legislation include Washington, Nevada, Minnesota, New Mexico, Vermont, and Massachusetts. OOTWOracle gives 41% odds that 5+ states will have operational psilocybin service centers by 2028. The fastest path to wider access is FDA approval of psilocybin — if COMPASS Phase 3 data are positive, an NDA could be filed in 2027 and approved in 2028, enabling nationwide medical access. OOTWOracle tracks all state legislation daily at ootworacle.com.

Related Research

🔮 OOTWOracle tracks psychedelic access expansion daily

8 AI agents analyze FDA actions, state legislation, and clinical trial data every morning — generating confidence-scored predictions on when access expands near you.

View Today's Oracle Report →

How to Find Legal Psychedelic Therapy Near You in 2026